These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 7982045)
1. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy. Rundfeldt C; Wlaź P; Löscher W Brain Res; 1994 Aug; 653(1-2):125-30. PubMed ID: 7982045 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669 [TBL] [Abstract][Full Text] [Related]
3. Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats. Wlaź P; Ebert U; Löscher W Eur J Neurosci; 1994 Nov; 6(11):1710-9. PubMed ID: 7874310 [TBL] [Abstract][Full Text] [Related]
4. The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds. Croucher MJ; Bradford HF Brain Res; 1991 Mar; 543(1):91-6. PubMed ID: 1647257 [TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats. Wlaź P; Ebert U; Löscher W Neuropharmacology; 1999 Feb; 38(2):243-51. PubMed ID: 10218865 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Löscher W Prog Neurobiol; 1998 Apr; 54(6):721-41. PubMed ID: 9560847 [TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant effects by combined treatment with a glycineB receptor antagonist and a polyamine site antagonist in amygdala-kindled rats. Ebert U; Wlaź P; Löscher W Eur J Pharmacol; 1997 Mar; 322(2-3):179-84. PubMed ID: 9098685 [TBL] [Abstract][Full Text] [Related]
8. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655 [TBL] [Abstract][Full Text] [Related]
9. Weak anticonvulsant effects of two novel glycineB receptor antagonists in the amygdala-kindling model in rats. Wlaź P; Löscher W Eur J Pharmacol; 1998 Jan; 342(1):39-46. PubMed ID: 9544790 [TBL] [Abstract][Full Text] [Related]
10. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Tober C; Rostock A; Rundfeldt C; Bartsch R Eur J Pharmacol; 1996 May; 303(3):163-9. PubMed ID: 8813562 [TBL] [Abstract][Full Text] [Related]
11. Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats. Namba T; Morimoto K; Yamada N; Otsuki S Pharmacol Biochem Behav; 1993 Oct; 46(2):275-81. PubMed ID: 8265681 [TBL] [Abstract][Full Text] [Related]
13. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice. Wlaź P; Baran H; Löscher W Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343 [TBL] [Abstract][Full Text] [Related]
14. Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats. Löscher W; Hönack D Eur J Pharmacol; 1993 Jul; 238(2-3):191-200. PubMed ID: 8405092 [TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. Löscher W; Hönack D J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593 [TBL] [Abstract][Full Text] [Related]
16. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861 [TBL] [Abstract][Full Text] [Related]
17. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists. Maj J; Rogóz Z; Skuza G; Kołodziejczyk K Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442 [TBL] [Abstract][Full Text] [Related]
18. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy. Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029 [TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy. Sato K; Morimoto K; Okamoto M Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606 [TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant activity of felbamate in amygdala kindling model of temporal lobe epilepsy in rats. Wlaź P; Löscher W Epilepsia; 1997 Nov; 38(11):1167-72. PubMed ID: 9579916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]